The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


VANGUARD 7.



Zoetis Belgium S.A.VPA10387/082/001

Main Information

Trade NameVANGUARD 7.
Active SubstancesLeptospira canicola inactivated
Leptospira icterohaemorrhagiae inactivated
Canine distemper virus strain N-CDV (live, attenuated)
Canine adenovirus type 2 virus, strain manhattan (live, attenuated)
Canine parainfluenza type 5 virus, strain NL-CPI-5 (live, attenuated)
Canine parvovirus strain NL-35-D (live, attenuated)
Dosage FormLyophilisate and solvent for solution for injection
Licence HolderZoetis Belgium S.A.
Licence NumberVPA10387/082/001

Group Information

ATC CodeQI07AI02 live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira
Therapeutic ClassImmunological
SpeciesDogs

Status

License statusAuthorised
Licence Issued12/09/2014
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back